Literature DB >> 28723299

Support for "Disease-Only" Genotypes and Excess of Homozygosity at the CYTH4 Primate-Specific GTTT-Repeat in Schizophrenia.

Ehteram Khademi1, Elham Alehabib2, Ehsan Esmaili Shandiz3, Azadeh Ahmadifard2, Monavvar Andarva2, Javad Jamshidi4, Simin Rahimi-Aliabadi2, Ramin Pouriran2, Farhad Ramezani Nejad5, Nader Mansoori5, Neda Shahmohammadibeni1, Shaghyegh Taghavi2, Parasto Shokraeian6, Haleh Akhavan-Niaki1, Coro Paisán-Ruiz7,8,9, Hossein Darvish1,2, Mina Ohadi10.   

Abstract

OBJECTIVE: The role of short tandem repeats (STRs) in the control of gene expression among species is being increasingly understood following the identification of several instances in which certain STRs occur identically, or expand differentially, in primates versus nonprimates. These STRs may regulate genes that participate in characteristics that are associated with the divergence of primates from sibling orders (e.g., brain higher order functions). The CYTH4 gene contains the longest tetranucleotide STR in its core promoter, at 7-repeats, and links to the evolution of human and nonhuman primates. Allele and genotype distribution of this STR were studied in patients affected by schizophrenia (SCZ) and controls.
METHODS: High-resolution data were obtained on the allele and genotype distribution of the CYTH4 STR and a novel C > T single-nucleotide polymorphism (SNP) at its immediate upstream sequence in 255 patients with SCZ and 249 controls. Each sample was sequenced twice using the fluorescent dye termination method.
RESULTS: Novel alleles were detected at the long extreme of the GTTT-repeat, at 10- and 11-repeats, in the SCZ cases and controls. Excess of homozygosity was observed for the entire range of alleles across the GTTT-repeat and the C > T SNP in the SCZ patients in comparison with the controls (Yates corrected p < 0.011). Three genotypes consisting of the 11-repeat allele (i.e., 11/11, 10/11, and 7/11) were detected only in the SCZ patients (i.e., disease-only genotypes), and contributed to 2.3% of the SCZ genotypes (Mid p exact <0.007). The frequency of the 11-repeat allele was estimated at 0.02 and 0.006 in the SCZ patients and controls, respectively (Mid p exact <0.006).
CONCLUSION: This indicates that STR genotypes that are absent in the control group may be risk factors for SCZ. Future studies are warranted to test the significance of our findings.

Entities:  

Keywords:  CYTH4; exceptionally long; primate-specific; schizophrenia; short tandem repeat

Mesh:

Substances:

Year:  2017        PMID: 28723299     DOI: 10.1089/gtmb.2016.0422

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  6 in total

1.  Skewing of the genetic architecture at the ZMYM3 human-specific 5' UTR short tandem repeat in schizophrenia.

Authors:  F Alizadeh; A Bozorgmehr; J Tavakkoly-Bazzaz; M Ohadi
Journal:  Mol Genet Genomics       Date:  2018-01-13       Impact factor: 3.291

2.  Genome-scale portrait and evolutionary significance of human-specific core promoter tri- and tetranucleotide short tandem repeats.

Authors:  N Nazaripanah; F Adelirad; A Delbari; R Sahaf; T Abbasi-Asl; M Ohadi
Journal:  Hum Genomics       Date:  2018-04-05       Impact factor: 4.639

3.  Natural selection at the RASGEF1C (GGC) repeat in human and divergent genotypes in late-onset neurocognitive disorder.

Authors:  Z Jafarian; S Khamse; H Afshar; H R Khorram Khorshid; A Delbari; M Ohadi
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.996

4.  The association of 20 short tandem repeat loci of autosomal chromosome with male schizophrenia.

Authors:  Chun Yang; Huajie Ba; Huihui Zou; Xianju Zhou
Journal:  Brain Behav       Date:  2022-06-08       Impact factor: 3.405

5.  Link between short tandem repeats and translation initiation site selection.

Authors:  Masoud Arabfard; Kaveh Kavousi; Ahmad Delbari; Mina Ohadi
Journal:  Hum Genomics       Date:  2018-10-29       Impact factor: 4.639

6.  Evolving evidence on a link between the ZMYM3 exceptionally long GA-STR and human cognition.

Authors:  H Afshar; S Khamse; F Alizadeh; A Delbari; R Najafipour; A Bozorgmehr; M Khazaei; F Adelirad; A Alizadeh; A Kowsari; M Ohadi
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.